CoChat

Drug‐induced liver injury: results from the hospital‐based Berlin Case–Control Surveillance Study

Open access
Douros, Antonios, Bronder, Elisabeth, Andersohn, Frank, Klimpel, Andreas, Thomae, Michael, Sarganas, Giselle, Kreutz, Reinhold, Garbe, Edeltraut · 2015 · British Journal of Clinical Pharmacology
Cited by 68

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Aim: Drug‐induced liver injury (DILI) is often responsible for acute liver failure, drug withdrawal, boxed warnings or drug non‐approval. Therefore, we conducted a case–control study to determine the hepatotoxic risk of a wide range of drugs. Methods: The B erlin Case–Control Surveillance Study FAKOS included all 51 B erlin hospitals in a hospital network. Between 2002 and 2011, 198 patients with acute idiopathic hepatitis, 377 inpatient controls and 708 outpatient controls were ascertained. Case patients were thoroughly validated using anamnestic, clinical, laboratory and histological data. Drug exposure was obtained in a face‐to‐face interview. A possible drug aetiology was assessed in individual patients by applying the updated Council for International Organizations of Medical Sciences (CIOMS) scale. Drug risks were further quantified [odds ratios (OR) with 95% confidence intervals (CI)] in a case–control design with unconditional logistic regression analysis. Drug intake in the last 28 days before index date was considered for the analysis. Results: The study corroborated hepatotoxic risks for a number of drugs, including phenprocoumon (OR 3.3, 95% CI 1.5, 6.7), amiodarone (OR 5.5, 95% CI 1.3, 21.2), clozapine (OR 34.6, 95% CI 2.8, 824.9) and flupirtine (OR 40.2, 95% CI 5.5, 856.9). Increased risks were also suggested for less commonly reported substances such as angiotensin II receptor blockers, atypical antipsychotics and for biperiden, a drug never before reported to be hepatotoxic. Conclusions: Our study identified a large number of drugs as possible causes of hepatotoxicity. The observed risk for seldom reported substances highlights the need for further post‐authorization safety studies not exclusively focusing on drugs already labelled as potentially hepatotoxic.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bcp.12565

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 68

Metadata

Authors
Douros, A., Bronder, E., Andersohn, F., Klimpel, A., Thomae, M., Sarganas, G., Kreutz, R., & Garbe, E.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2015-05-22
Volume
79
Issue
6
Pages
988-999
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W1923117400
Cited by
68
References
6
FWCI
5.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug‐induced liver injury: results from the hospital‐based Berlin Case–Control Surveillance Study. https://app.cochat.ai/papers/10.1111/bcp.12565
The paper
Douros, A., Bronder, E., Andersohn, F., Klimpel, A., Thomae, M., Sarganas, G., Kreutz, R., & Garbe, E. (2015). Drug‐induced liver injury: results from the hospital‐based Berlin Case–Control Surveillance Study. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.12565

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.